EP 0801566 A4 19980429 - 4,4-(DISUBSTITUTED)CYCLOHEXAN-1-YLIDINE ACETATE MONOMERS AND RELATED COMPOUNDS
Title (en)
4,4-(DISUBSTITUTED)CYCLOHEXAN-1-YLIDINE ACETATE MONOMERS AND RELATED COMPOUNDS
Title (de)
4,4-(DISUBSTITUIERTE)CYCLOHEXAN-1-YLIDIN ACETAT MONOMERE UND VERWANDTE VERBINDUNGEN
Title (fr)
MONOMERES DE 4,4-(DISUBSTITUE)CYCLOHEXAN-1-YLIDINE ACETATE ET COMPOSES APPARENTES
Publication
Application
Priority
- US 9516707 W 19951221
- US 36270794 A 19941223
Abstract (en)
[origin: WO9619992A1] The present invention relates to novel 4,4-(disubstituted)cyclohexan-1-ylidine acetate monomers and related compounds, pharmaceutical compositions containing these compounds, and their use in treating allergic and inflammatory diseases and for inhibiting the production of Tumor Necrosis Factor (TNF).
IPC 1-7
IPC 8 full level
A61K 31/44 (2006.01); A61P 43/00 (2006.01); C07D 213/55 (2006.01); C07D 213/57 (2006.01)
CPC (source: EP)
A61P 43/00 (2017.12); C07D 213/55 (2013.01); C07D 213/57 (2013.01)
Citation (search report)
- [AD] WO 9319748 A1 19931014 - SMITHKLINE BEECHAM CORP [US], et al
- See references of WO 9619992A1
Designated contracting state (EPC)
BE CH DE DK FR GB IT LI NL
DOCDB simple family (publication)
WO 9619992 A1 19960704; EP 0801566 A1 19971022; EP 0801566 A4 19980429; JP H10511394 A 19981104
DOCDB simple family (application)
US 9516707 W 19951221; EP 95943939 A 19951221; JP 52052596 A 19951221